Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Interleukin Genetics Inc

+ Add to Watchlist

ILIU:US

0.1550 USD 0.0025 1.59%

As of 20:10:00 ET on 04/17/2015.

Snapshot for Interleukin Genetics Inc (ILIU)

Open: 0.1500 Day's Range: 0.1500 - 0.1575 Volume: 41,405
Previous Close: 0.1575 52wk Range: 0.0527 - 0.4599 1-Yr Rtn: -48.30%

Stock Chart for ILIU

No chart data available.
  • ILIU:US 0.1550
  • 1D
  • 1M
  • 1Y
0.1575
Interactive ILIU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ILIU

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0400
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 26.77
Shares Outstanding (M) 172.74
30 Day Average Volume 50,494
Price/Book (mrq) 5.9258
Price/Sale (ttm) 11.0614
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ILIU

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ILIU

Interleukin Genetics, Inc. develops and commercializes genetic diagnostic tests and medical research tools. The Company's PST, a test predictive of risk for periodontal disease, is currently available in the United States. Interleukin also develops and licenses its medical research tools, such as BioFusion, to pharmaceutical companies for use in drug discovery and development.

Kenneth S Kornman "Ken"Pres/Chief Scientific OfcrMark B CarbeauChief Executive Officer
Stephen J DipalmaInterim CFOScott A SnyderChief Marketing Officer
More Company Profile & Key Executives for ILIU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil